766 related articles for article (PubMed ID: 23439366)
21. Diversity, evolution, and therapeutic applications of small RNAs in prokaryotic and eukaryotic immune systems.
Cooper EL; Overstreet N
Phys Life Rev; 2014 Mar; 11(1):113-34. PubMed ID: 24286719
[TBL] [Abstract][Full Text] [Related]
22. The basic building blocks and evolution of CRISPR-CAS systems.
Makarova KS; Wolf YI; Koonin EV
Biochem Soc Trans; 2013 Dec; 41(6):1392-400. PubMed ID: 24256226
[TBL] [Abstract][Full Text] [Related]
23. CRISPR-Cas systems and RNA-guided interference.
Barrangou R
Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
[TBL] [Abstract][Full Text] [Related]
24. CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity.
Barrangou R; Marraffini LA
Mol Cell; 2014 Apr; 54(2):234-44. PubMed ID: 24766887
[TBL] [Abstract][Full Text] [Related]
25. Mobile Genetic Elements and Evolution of CRISPR-Cas Systems: All the Way There and Back.
Koonin EV; Makarova KS
Genome Biol Evol; 2017 Oct; 9(10):2812-2825. PubMed ID: 28985291
[TBL] [Abstract][Full Text] [Related]
26. A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action.
Makarova KS; Grishin NV; Shabalina SA; Wolf YI; Koonin EV
Biol Direct; 2006 Mar; 1():7. PubMed ID: 16545108
[TBL] [Abstract][Full Text] [Related]
27. Pseudo-chaotic oscillations in CRISPR-virus coevolution predicted by bifurcation analysis.
Berezovskaya FS; Wolf YI; Koonin EV; Karev GP
Biol Direct; 2014 Jul; 9():13. PubMed ID: 24986220
[TBL] [Abstract][Full Text] [Related]
28. Clustered regularly interspaced short palindromic repeats (CRISPRs): the hallmark of an ingenious antiviral defense mechanism in prokaryotes.
Al-Attar S; Westra ER; van der Oost J; Brouns SJ
Biol Chem; 2011 Apr; 392(4):277-89. PubMed ID: 21294681
[TBL] [Abstract][Full Text] [Related]
29. The ecology and evolution of microbial CRISPR-Cas adaptive immune systems.
Westra ER; van Houte S; Gandon S; Whitaker R
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20190101. PubMed ID: 30905294
[No Abstract] [Full Text] [Related]
30. Suppressing the CRISPR/Cas adaptive immune system in bacterial infections.
Gholizadeh P; Aghazadeh M; Asgharzadeh M; Kafil HS
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2043-2051. PubMed ID: 28601970
[TBL] [Abstract][Full Text] [Related]
31. CRISPR-Cas System: The Powerful Modulator of Accessory Genomes in Prokaryotes.
Butiuc-Keul A; Farkas A; Carpa R; Iordache D
Microb Physiol; 2022; 32(1-2):2-17. PubMed ID: 34192695
[TBL] [Abstract][Full Text] [Related]
32. Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms.
Koonin EV; Wolf YI
Biol Direct; 2016 Feb; 11(1):9. PubMed ID: 26912144
[TBL] [Abstract][Full Text] [Related]
33. CRISPR-Cas adaptation: insights into the mechanism of action.
Amitai G; Sorek R
Nat Rev Microbiol; 2016 Feb; 14(2):67-76. PubMed ID: 26751509
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of CRISPR-Cas spacer acquisition.
McGinn J; Marraffini LA
Nat Rev Microbiol; 2019 Jan; 17(1):7-12. PubMed ID: 30171202
[TBL] [Abstract][Full Text] [Related]
35. Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family.
Hrle A; Maier LK; Sharma K; Ebert J; Basquin C; Urlaub H; Marchfelder A; Conti E
RNA Biol; 2014; 11(8):1072-82. PubMed ID: 25483036
[TBL] [Abstract][Full Text] [Related]
36. Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity.
Charpentier E; Richter H; van der Oost J; White MF
FEMS Microbiol Rev; 2015 May; 39(3):428-41. PubMed ID: 25994611
[TBL] [Abstract][Full Text] [Related]
37. Nature and intensity of selection pressure on CRISPR-associated genes.
Takeuchi N; Wolf YI; Makarova KS; Koonin EV
J Bacteriol; 2012 Mar; 194(5):1216-25. PubMed ID: 22178975
[TBL] [Abstract][Full Text] [Related]
38. Unprecedented Diversity of Unique CRISPR-Cas-Related Systems and Cas1 Homologs in Asgard Archaea.
Makarova KS; Wolf YI; Shmakov SA; Liu Y; Li M; Koonin EV
CRISPR J; 2020 Jun; 3(3):156-163. PubMed ID: 33555973
[TBL] [Abstract][Full Text] [Related]
39. Five big mysteries about CRISPR's origins.
Ledford H
Nature; 2017 Jan; 541(7637):280-282. PubMed ID: 28102279
[No Abstract] [Full Text] [Related]
40. Characterization and Repurposing of Type I and Type II CRISPR-Cas Systems in Bacteria.
Hidalgo-Cantabrana C; Goh YJ; Barrangou R
J Mol Biol; 2019 Jan; 431(1):21-33. PubMed ID: 30261168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
